Piper Sandler Upgrades HomeStreet to Neutral

Piper Sandler analyst Matthew Clark upgrades HomeStreet (NASDAQ:HMST) from Underweight to Neutral.

Piper Sandler analyst Matthew Clark upgrades HomeStreet (NASDAQ:HMST) from Underweight to Neutral.

Total
0
Shares
Related Posts
Read More

Pfizer Says U.S. FDA Approved Company’s BEQVEZ (fidanacogene elaparvovec-dzkt), A One-Time Gene Therapy For Adults With Hemophilia B; Company Now Plans Launching An Innovative Warranty Program Based On Durability Of Patient Response To Treatment

With BEQVEZ now approved for use, Pfizer is launching an innovative warranty program based on durability of patient response to treatment. The goal of the warranty is to provide greater certainty to payers, maximize

PFE